BioPharma Resources

Drug Trial Radar · NCT07850752

A Study of the Efficacy and Safety of Zigakibart + Atrasentan in Adult Patients With Primary IgA Nephropathy

A Phase IIIb, Multi-center, Two-arm, Randomized, Double-blind, Parallel Group Study to Evaluate the Efficacy and Safety of Zigakibart and Atrasentan Versus Zigakibart and Placebo in Patients With Primary IgA Nephropathy

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 340 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

340

Planned (sponsor's estimate)

Start

Nov 11, 2026

Primary completion

Sep 17, 2028

Study completion Dec 25, 2030

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Sep 30, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase IIIb, multicenter, two-arm, randomized, double-blind, parallel group study to evaluate the efficacy and safety of zigakibart + atrasentan compared to zigakibart + placebo in patients with primary IgAN at risk of disease progression.

Conditions

  • IgA Nephropathy (IgAN)

Interventions

  • zigakibartBiological

    Solution for injection via PFS-NSD

  • atrasentanDrug

    Tablet

  • PlaceboDrug

    Tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in proteinuria from Baseline to Week 36, based on 24 hour urine collectionTime frame: Baseline, Week 36

Locations

11 sites in 3 countries. Site status is shown where the registry gives one.

  • Nephrology Consultants LLC

    Huntsville, Alabama · Recruiting

  • West Coast Kidney Institute

    Fremont, California · Recruiting

  • Nephrology Associates PA

    Newark, Delaware · Recruiting

  • Florida Kidney Physicians

    Riverview, Florida · Recruiting

  • Florida Kidney Physicians LLC

    Temple Terrace, Florida · Recruiting

  • Southeast Kidney Associates

    East Point, Georgia · Recruiting

  • DaVita Clinical Research

    Las Vegas, Nevada · Recruiting

  • Northern Assoc of Northern VA

    Fairfax, Virginia · Recruiting

  • Novartis Investigative Site

    Nedlands, Western Australia, Australia · Recruiting

  • Novartis Investigative Site

    Beersheba, Israel · Recruiting

  • Novartis Investigative Site

    Petah Tikva, Israel · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.